Aadi Bioscience, Inc. / Fundamentals
Income statement
- Net revenue
€18.61M - Cost of goods sold
€2.03M - Gross profit
€16.58M - SG&A expenses
€31.87M - R&D expenses
€70.60M - EBITDA
-€87.30M - D&A
€80.99K - EBIT
-€88.16M - Interest expenses
€32.74K - EBT
-€8.98M - Tax expenses
€0.00 - Net income
-€8.98M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€84.12M - Changes in working capital
-€2.91M - Operating cash flow
-€82.33M - Capex
-€1.32M - Other investing cash flow
€108.09M - Net investing cash flow
€90.37M - Total cash dividends paid
€0.00 - Issuance of common stock
€86.16M - Debt repayment
€0.00 - Other financing cash flow
-€25.89M - Net financing cash flow
€81.33M - Foreign exchange effects
€0.00 - Net change in cash
€89.37M - Cash at end of period
€124.87M - Free cash flow
-€83.65M
Balance sheet
- Cash and cash equivalents
€124.87M - Cash and short-term investments
€152.67M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€1.27M - Total current assets
€153.93M - Property, plant & equipment
€7.75K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€1.85M - Total non-current assets
€1.85M - Total assets
€155.79M - Accounts payable
€2.88M - Short-term debt
€0.00 - Other current liabilities
€4.67M - Total current liabilities
€7.54M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€7.54M - Common stock
€3.45K - Retained earnings
-€269.02M - Other equity
€7.75K - Total equity
€148.24M - Total liabilities and shareholders' equity
€155.79M
Company information
- Market capitalization
€80.94M - Employees
53 - Enterprise Value
-€133.35M
Company ratios
- Gross margin
-
89.1% Much better than peer group: -105,143,297,309,467.6% - EBITDA margin
-
-469.2% Much better than peer group: -578,148,314,990,871.1% - EBIT margin
-
-473.8% Much better than peer group: -583,545,567,861,225.4% - EBT margin
-
-48.2% Much better than peer group: -582,853,087,335,196.4% - Net margin
-
-48.2% Much better than peer group: -582,853,087,335,186.2% - ROE
-
-6.1% Much better than peer group: -238.0% - ROA
-
-5.8% Much better than peer group: -110.6% - Asset turnover
-
11.9% Worse than peer group: 20.9% - FCF margin
-
-435.4% Much better than peer group: -485,644,208,179,993.0% - FCF yield
-100.1% - Efficiency ratio
569.2% - Net sales per employee
-
€351.06K - Net income per employee
-
-€169.35K